The study links early-life sugar exposure to chronic disease risk, suggesting that sugar restriction could enhance health and reduce diabetes and hypertension.
Breaking: AbbVie Inks Deal with Gilgamesh Pharmaceuticals – Psychedelic Alpha
AbbVie has become the latest large pharmaceutical company to dip its toes into psychedelic drug development as it announced what might be the most substantial foray